Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropin-releasing hormone.
暂无分享,去创建一个
G. Garzo | D. Meldrum | J. Rivier | F. Hamilton | A. Wisot | C. Stubbs
[1] R. Spirtas,et al. Fertility drugs and ovarian cancer: red alert or red herring? , 1993, Fertility and sterility.
[2] D. Meldrum. Female reproductive aging--ovarian and uterine factors , 1993 .
[3] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[4] L. Regan,et al. Hypersecretion of luteinising hormone, infertility, and miscarriage , 1990, The Lancet.
[5] W. Vale,et al. Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies. , 1989, Fertility and sterility.